| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group | 
| Product containing precisely benzocaine 10 milligram/1 milliliter and triclosan 2 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) | Has manufactured dose form | True | Conventional release cutaneous lotion (dose form) | Inferred relationship | Some |  | 
| Bentoquatam 50 mg/mL cutaneous lotion | Has manufactured dose form | True | Conventional release cutaneous lotion (dose form) | Inferred relationship | Some |  | 
| ammoniumlaktat 1 %, lotion | Has manufactured dose form | False | Conventional release cutaneous lotion (dose form) | Inferred relationship | Some |  | 
| Product containing precisely urea 100 milligram/1 gram conventional release cutaneous lotion (clinical drug) | Has manufactured dose form | True | Conventional release cutaneous lotion (dose form) | Inferred relationship | Some |  | 
| Product containing precisely crotamiton 100 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) | Has manufactured dose form | True | Conventional release cutaneous lotion (dose form) | Inferred relationship | Some |  | 
| betametason 0,1 %, lotion | Has manufactured dose form | False | Conventional release cutaneous lotion (dose form) | Inferred relationship | Some |  | 
| Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 milliliter conventional release cutaneous lotion (clinical drug) | Has manufactured dose form | True | Conventional release cutaneous lotion (dose form) | Inferred relationship | Some |  | 
| Mometasone furoate 1 mg/g cutaneous lotion | Has manufactured dose form | True | Conventional release cutaneous lotion (dose form) | Inferred relationship | Some |  | 
| Coal tar 10 mg/mL cutaneous lotion | Has manufactured dose form | True | Conventional release cutaneous lotion (dose form) | Inferred relationship | Some |  | 
| Allantoin 20 mg/g and coal tar extract 50 mg/g cutaneous lotion | Has manufactured dose form | True | Conventional release cutaneous lotion (dose form) | Inferred relationship | Some |  | 
| Tretinoin 250 microgram/g cutaneous lotion | Has manufactured dose form | True | Conventional release cutaneous lotion (dose form) | Inferred relationship | Some |  | 
| Product containing precisely benzoyl peroxide 50 milligram/1 gram conventional release cutaneous lotion (clinical drug) | Has manufactured dose form | True | Conventional release cutaneous lotion (dose form) | Inferred relationship | Some |  | 
| Benzoyl peroxide 100 mg/g cutaneous lotion | Has manufactured dose form | True | Conventional release cutaneous lotion (dose form) | Inferred relationship | Some |  | 
| Product containing precisely salicylic acid 20 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) | Has manufactured dose form | True | Conventional release cutaneous lotion (dose form) | Inferred relationship | Some |  | 
| Product containing precisely phenothrin 2 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) | Has manufactured dose form | True | Conventional release cutaneous lotion (dose form) | Inferred relationship | Some |  | 
| Aluminium acetate 6.5 mg/mL cutaneous lotion | Has manufactured dose form | True | Conventional release cutaneous lotion (dose form) | Inferred relationship | Some |  | 
| sulfacetamid 10 %, lösning | Has manufactured dose form | False | Conventional release cutaneous lotion (dose form) | Inferred relationship | Some |  | 
| Product containing precisely metronidazole 7.5 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) | Has manufactured dose form | True | Conventional release cutaneous lotion (dose form) | Inferred relationship | Some |  | 
| Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram conventional release cutaneous lotion (clinical drug) | Has manufactured dose form | True | Conventional release cutaneous lotion (dose form) | Inferred relationship | Some |  | 
| Product containing precisely desonide 500 microgram/1 milliliter conventional release cutaneous lotion (clinical drug) | Has manufactured dose form | True | Conventional release cutaneous lotion (dose form) | Inferred relationship | Some |  | 
| hydrokortison 2 %, lotion för lokalt bruk | Has manufactured dose form | False | Conventional release cutaneous lotion (dose form) | Inferred relationship | Some |  | 
| klindamycinfosfat 10 milligram/milliliter, hudlotion | Has manufactured dose form | False | Conventional release cutaneous lotion (dose form) | Inferred relationship | Some |  | 
| Product containing precisely hydrocortisone 5 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) | Has manufactured dose form | True | Conventional release cutaneous lotion (dose form) | Inferred relationship | Some |  | 
| Selenium sulfide 25 mg/mL cutaneous lotion | Has manufactured dose form | True | Conventional release cutaneous lotion (dose form) | Inferred relationship | Some |  | 
| Urea 400 mg/mL cutaneous lotion | Has manufactured dose form | True | Conventional release cutaneous lotion (dose form) | Inferred relationship | Some |  | 
| Product containing precisely amphotericin B 30 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) | Has manufactured dose form | True | Conventional release cutaneous lotion (dose form) | Inferred relationship | Some |  | 
| hydrokortison 2,5 %, lotion | Has manufactured dose form | False | Conventional release cutaneous lotion (dose form) | Inferred relationship | Some |  | 
| Hydrocortisone 10 mg/mL cutaneous lotion | Has manufactured dose form | True | Conventional release cutaneous lotion (dose form) | Inferred relationship | Some |  | 
| Product containing precisely sulfacetamide sodium 100 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) | Has manufactured dose form | True | Conventional release cutaneous lotion (dose form) | Inferred relationship | Some |  | 
| betametasondipropionat 0,05 %, lotion | Has manufactured dose form | False | Conventional release cutaneous lotion (dose form) | Inferred relationship | Some |  | 
| Clotrimazole 10 mg/mL cutaneous lotion | Has manufactured dose form | True | Conventional release cutaneous lotion (dose form) | Inferred relationship | Some |  | 
| Product containing precisely hydrocortisone 25 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) | Has manufactured dose form | True | Conventional release cutaneous lotion (dose form) | Inferred relationship | Some |  | 
| Fludroxycortide 500 microgram/mL cutaneous lotion | Has manufactured dose form | True | Conventional release cutaneous lotion (dose form) | Inferred relationship | Some |  | 
| Product containing precisely methoxsalen 10 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) | Has manufactured dose form | True | Conventional release cutaneous lotion (dose form) | Inferred relationship | Some |  | 
| Clobetasol propionate 500 microgram/mL cutaneous lotion | Has manufactured dose form | True | Conventional release cutaneous lotion (dose form) | Inferred relationship | Some |  | 
| Amcinonide 1 mg/mL cutaneous lotion | Has manufactured dose form | True | Conventional release cutaneous lotion (dose form) | Inferred relationship | Some |  | 
| Product containing precisely erythromycin 20 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) | Has manufactured dose form | True | Conventional release cutaneous lotion (dose form) | Inferred relationship | Some |  | 
| Product containing precisely fluticasone propionate 500 microgram/1 milliliter conventional release cutaneous lotion (clinical drug) | Has manufactured dose form | True | Conventional release cutaneous lotion (dose form) | Inferred relationship | Some |  | 
| Triamcinolone acetonide 1 mg/mL cutaneous lotion | Has manufactured dose form | True | Conventional release cutaneous lotion (dose form) | Inferred relationship | Some |  | 
| Product containing precisely benzyl alcohol 50 microliter/1 milliliter conventional release cutaneous lotion (clinical drug) | Has manufactured dose form | True | Conventional release cutaneous lotion (dose form) | Inferred relationship | Some |  | 
| Clindamycin (as clindamycin phosphate) 10 mg/mL cutaneous lotion | Has manufactured dose form | True | Conventional release cutaneous lotion (dose form) | Inferred relationship | Some |  | 
| Hydrocortisone butyrate 1 mg/mL cutaneous lotion | Has manufactured dose form | True | Conventional release cutaneous lotion (dose form) | Inferred relationship | Some |  | 
| Product containing precisely malathion 5 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) | Has manufactured dose form | True | Conventional release cutaneous lotion (dose form) | Inferred relationship | Some |  | 
| Adapalene 1 mg/mL cutaneous lotion | Has manufactured dose form | True | Conventional release cutaneous lotion (dose form) | Inferred relationship | Some |  | 
| Carbaryl 5 mg/mL cutaneous lotion | Has manufactured dose form | True | Conventional release cutaneous lotion (dose form) | Inferred relationship | Some |  | 
| Tetracycline 10 mg/mL cutaneous lotion | Has manufactured dose form | True | Conventional release cutaneous lotion (dose form) | Inferred relationship | Some |  | 
| Product containing precisely ciclopirox (as ciclopirox olamine) 7.7 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) | Has manufactured dose form | True | Conventional release cutaneous lotion (dose form) | Inferred relationship | Some |  | 
| Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1 milliliter and calcipotriol 50 microgram/1 milliliter conventional release cutaneous lotion (clinical drug) | Has manufactured dose form | True | Conventional release cutaneous lotion (dose form) | Inferred relationship | Some |  | 
| Hydrocortisone acetate 20 mg/mL cutaneous lotion | Has manufactured dose form | True | Conventional release cutaneous lotion (dose form) | Inferred relationship | Some |  | 
| Product containing precisely coal tar 400 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) | Has manufactured dose form | True | Conventional release cutaneous lotion (dose form) | Inferred relationship | Some |  | 
| Product containing precisely betamethasone valerate 1 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) | Has manufactured dose form | True | Conventional release cutaneous lotion (dose form) | Inferred relationship | Some |  | 
| Product containing precisely coal tar 40 milligram/1 milliliter and ketoconazole 20 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) | Has manufactured dose form | True | Conventional release cutaneous lotion (dose form) | Inferred relationship | Some |  | 
| Lindane 10 mg/mL cutaneous lotion | Has manufactured dose form | True | Conventional release cutaneous lotion (dose form) | Inferred relationship | Some |  |